RxDoctor Payments Data

David Mener, MD

Pediatric Otolaryngology · New Rochelle, NYNPI 1124346242

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,100 of the $4,029 with a category attached, or 76.9%. It is spread thinly across 23 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,083 and has fallen 51.6% since, to $524 in 2025. Among pediatric otolaryngology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,029in general payments, 2019–2025

Across 125 payments — averaging $32.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$746
  • Verathon Inc.$550
  • Sanofi$534
  • Optinose US, Inc.$387
  • Novartis$382
  • Stryker$328
  • plus $1K from 17 others

What the payments were for

  • Consulting fees$83021%
  • Food & beverage$3,10077%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,029 in reported general payments places this provider in the 90th percentile of 39 pediatric otolaryngology providers in New York.

See all pediatric otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$102,377
Medicare patients
265
Services billed
789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl181$3,381
Ipratropium Bromide87$2,215
Fluticasone Propionate294$2,161
Omeprazole84$469
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort11$439
Montelukast Sodium14$243
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$226
Cefdinir11$181
Prednisone18$58

Paid to pharmacies, not to this prescriber.

Other pediatric otolaryngology in New Rochelle

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →